Local news, photos, and videos from Minnesota. Minnesota Headline brings you the best in Minnesota news online, anytime.

Developed in China, Protecting Lives Worldwide: Cofoe Medical Showcases Its Innovative Product Portfolio at MEDICA 2026

Nov 18, 2026

-- From November 16 to 19, MEDICA 2026, one of the world's largest B2B trade fairs for medical technology and healthcare, is taking place at Messe Düsseldorf in Germany. Bringing together more than 4,800 exhibitors from over 70 countries and regions and attracting more than 70,000 trade visitors, the event spans the entire healthcare value chain, including medical imaging, diagnostics, digital health, rehabilitation and care, and medical consumables. Widely regarded as a global barometer of medical innovation and a key platform for turning innovation into practical applications, MEDICA continues to shape the future of the healthcare industry.

Once again invited to participate in this premier global industry event, Cofoe Medical is showcasing its latest innovations in Hall 11, including its dual-test strips for blood glucose and uric acid, continuous glucose monitoring (CGM) system, and C11 AI-powered ventilator. Through this portfolio of core technologies and products, the company is demonstrating to the world the depth of its in-house R&D capabilities and its integrated approach to developing home medical devices as a Chinese manufacturer.

Redefining the Smart Healthcare Experience Through In-House Innovation

Cofoe's presence at MEDICA 2026 is guided by a clear vision: leveraging breakthroughs in core technologies to make professional healthcare smarter and more accessible in everyday life.

The dual-test strips for blood glucose and uric acid are one of Cofoe Medical's flagship innovations at this year's exhibition. Powered by a self-developed, single-channel electrochemical biosensor, the technology enables simultaneous measurement of blood glucose and uric acid from just a single drop of blood. By addressing the technical challenge of multi-parameter testing, it introduces a globally pioneering technological approach, offering users who need to monitor multiple metabolic indicators a simpler and more convenient way to manage their health.

In April 2026, Cofoe's continuous glucose monitoring (CGM) system obtained China's Class III medical device registration certificate. With a mean absolute relative difference (MARD) of 6.75%, the system supports up to 14 days of continuous monitoring, intelligent high- and low-glucose alerts, and remote data sharing. It also enables data connectivity with AI glasses, helping break down platform barriers and create a more connected health management experience.

The C11 AI-powered ventilator features a dual-AI architecture combining a cloud-based health foundation model with an on-device 3S intelligent synchronization algorithm. Its multi-stage acoustic design delivers quiet operation at noise levels as low as 23 dB. With independent control over key technologies spanning algorithms, blower systems, and airway structures, the C11 demonstrates new possibilities for Chinese-developed innovation in premium home healthcare equipment.

From Individual Innovations to a Comprehensive Portfolio for Lifelong Health

Building on its in-house innovation capabilities, Cofoe has brought its comprehensive product portfolio to Düsseldorf, showcasing integrated solutions across health monitoring, respiratory support, medical care, and rehabilitation and mobility assistance.The wound care products and ostomy supplies from its subsidiary HZ PSA further extend its offerings into home care, while electric wheelchairs from its subsidiary Jerry Medical address mobility and caregiving needs in rehabilitation settings. Together with established product lines such as blood pressure monitors, nebulizers, and oxygen concentrators, Cofoe has brought together a connected portfolio spanning preventive monitoring, chronic disease management, nursing care, and rehabilitation. This enables smart healthcare solutions to support more stages of the home health journey.

Global Partnerships, Built on Trust and Collaboration

Throughout the exhibition, Cofoe's booth welcomed customers and distributors from across Europe, North America, Latin America, Asia, Africa, and other regions. Innovative products such as the dual-test strips for blood glucose and uric acid, the C11 AI-powered ventilator, and the CGM system became major attractions, while a wide range of other products—including atrial fibrillation blood pressure monitors, smart nebulizers, oxygen concentrators, thermometers, and pulse oximeters—also drew considerable interest, with many visitors taking the opportunity to experience them firsthand.

During the exhibition, Cofoe also held its annual key customer awards ceremony at the booth, presenting trophies to valued partners from multiple countries in recognition of their longstanding trust and close collaboration. Cofoe's commitment to in-house innovation and global expansion goes hand in hand with the growth of its international partners. The strong recognition it continues to receive from markets around the world underscores the long-term value of China's smart manufacturing in contributing to the global healthcare industry.

Bringing China's Smart Manufacturing to the Future of Global Healthcare

Yu Xiangyu, Vice President of Cofoe Medical, said at the exhibition: "MEDICA brings together key decision-makers in medical technology and procurement from around the world. We are here with our proprietary technologies, comprehensive product portfolio, and well-established smart manufacturing capabilities. What we are showcasing is not simply a collection of individual products, but the full strength of Cofoe as a Chinese home healthcare brand."

Cofoe's strategy is clear: to deepen its R&D efforts in critical areas such as sensors, algorithms, and core components, while leveraging the resources and capabilities of its dual A-share and H-share listed platforms to bring the benefits of accessible home healthcare solutions developed in China to more households worldwide.

Today, Chinese medical device companies are playing an increasingly active role in shaping the global home healthcare market through innovative, intelligent products developed in-house. Cofoe sees this exhibition as another milestone in its global journey. Moving forward, the company will continue to leverage smart healthcare and China's smart manufacturing to make more comfortable and accessible healthcare services available to households around the world.

Smart Healthcare, Within Everyone's Reach.

Contact Info:
Name: Jack Pan
Email: Send Email
Organization: Cofoe Medical Technology Co., Ltd.
Website: https://www.cofoe.com

Release ID: 89210029

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.

Looking for Local Media Coverage in the United States of America?

We have a place for all 50 States at the State News Network

What's Hot

More News

Press Releases